losartan and codeine
losartan has been researched along with codeine in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Laine, K; Tirkkonen, T | 1 |
| Eliasson, E; Mannheimer, B | 1 |
Reviews
3 review(s) available for losartan and codeine
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-drug interactions that reduce the formation of pharmacologically active metabolites: a poorly understood problem in clinical practice.
Topics: Analgesics, Opioid; Angiotensin II Type 1 Receptor Blockers; Antineoplastic Agents, Hormonal; Biotransformation; Clopidogrel; Codeine; Drug Interactions; Humans; Losartan; Platelet Aggregation Inhibitors; Tamoxifen; Ticlopidine | 2010 |
Other Studies
5 other study(ies) available for losartan and codeine
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Drug interactions with the potential to prevent prodrug activation as a common source of irrational prescribing in hospital inpatients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analgesics, Opioid; Antihypertensive Agents; Aryl Hydrocarbon Hydroxylases; Biotransformation; Codeine; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6 Inhibitors; Databases, Nucleic Acid; Drug Interactions; Drug Prescriptions; Enzyme Inhibitors; Female; Humans; Losartan; Male; Medication Errors; Medication Systems, Hospital; Middle Aged; Prodrugs; Sex Factors; Tramadol | 2004 |